text.skipToContent text.skipToNavigation
Need help? Please contact us
You searched for "Therapro"
Too many choices? Use the filter option on the left to narrow your product listing.
Did you mean: therapy?
1-4 of 4 results
Applied Filter
  • Protein Production 
    TheraPRO<sup class=reg>®</sup> CHO Expansion Medium - 1L
    Compare
    TheraPRO® CHO Expansion Medium - 1L
    Catalog #: BESP1630Q
    Chemically defined, non-animal origin (NAO), serum-free medium
    EA
    TheraPRO<sup class=reg>®</sup> CHO Feed - 5L
    Compare
    TheraPRO® CHO Feed - 5L
    Catalog #: BESP1603BX

    Chemically defined, non-animal origin (NAO), serum-free medium

    EA
    TheraPRO<sup class=reg>®</sup> CHO Production Medium - 5L
    Compare
    TheraPRO® CHO Production Medium - 5L
    Catalog #: BESP1571B

    Chemically defined, non-animal origin (NAO), serum-free medium

    EA
    TheraPRO<sup class=reg>®</sup> CHO Cloning Medium - 1L
    Compare
    TheraPRO® CHO Cloning Medium - 1L
    Catalog #: BESP1609Q
    Chemically defined, non-animal origin (NAO), serum-free medium
    EA
1-10 of 58 results
  • TheraPRO® CHO Media System
    Toss sheet used to promote the TheraPRO CHO Media System
  • TheraPRO® CHO Instructions for Use
    Instructions on how to use the TheraPRO® CHO Media System
  • TheraPRO® CHO Scalability Therapeutic Protein Production, Simplified
    Whitepaper focusing on the scalability of the TheraPRO® CHO expansion medium
  • Cell Therapy Capabilities
  • Pluripotent Stem Cell Innovation Center – Building Bridges from Research to Therapy
    Translational Stem Cell Research, Cell Therapy & Drug Development
  • TheraPEAK® X-VIVO® Hematopoietic Cell Culture Medium
    Serum-free, GMP produced medium for cell therapy applications
  • Digitalizing Cell & Gene Therapy Manufacturing
    Case study examining how MES Solutions improve operational efficiency and save costs.
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
  • 4D-Nucleofector® LV Unit for Large-scale Transfection
    Efficient, closed and scalable transfection for ex vivo cell and gene therapy applications
  • Developing Patient-specific Cell Therapy Manufacturing Processes
    Poster presentation about patient-specific cellular therapies and their tremendous potential for being able to treat life threatening diseases where there are currently no cures.